Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More - Disc Medicine (NASDAQ:IRON), Bristol-Myers Squibb (NYSE:BMY)
Pipeline and regulatory updates continue to be in focus in the biotech sector. While nothing much came out of bigwigs apart from a few, shares of clinical-stage biotechs like Disc Medicine, Inc.
Source: benzinga.com